LetterLetter
Improving Outcomes for Patients With Hemophagocytic Lymphohistiocytosis
Meaghan Rousset and Anish Ray
The Journal of Rheumatology November 2022, jrheum.221010; DOI: https://doi.org/10.3899/jrheum.221010
Meaghan Rousset
Anne Burnett Marion School of Medicine at Texas Christian University; Department of Pediatric Hematology/Oncology, Cook Children's Medical Center, Fort Worth, Texas. The authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. A. Ray, Department of Pediatric Hematology/Oncology, Cook Children's Health Care System, 1500 Cooper St., 5th floor, Fort Worth, TX, 76104, USA. Email: Anish.Ray@CookChildrens.org.
Anish Ray
Anne Burnett Marion School of Medicine at Texas Christian University; Department of Pediatric Hematology/Oncology, Cook Children's Medical Center, Fort Worth, Texas. The authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. A. Ray, Department of Pediatric Hematology/Oncology, Cook Children's Health Care System, 1500 Cooper St., 5th floor, Fort Worth, TX, 76104, USA. Email: Anish.Ray@CookChildrens.org.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 3
1 Mar 2024
Improving Outcomes for Patients With Hemophagocytic Lymphohistiocytosis
Meaghan Rousset, Anish Ray
The Journal of Rheumatology Nov 2022, jrheum.221010; DOI: 10.3899/jrheum.221010